Literature DB >> 12498388

Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.

Kasem Nithipatikom1, Marilyn A Isbell, Paul F Lindholm, Andre Kajdacsy-Balla, Sushma Kaul, William B Campell.   

Abstract

The PC-3 Low Invasive cells and the PC-3 High Invasive cells were used to investigate the correlation of the COX-2 expression and its arachidonic acid metabolites, prostaglandins, with their invasiveness through Matrigel using a Boyden chamber assay. The COX-2 expression in PC-3 High Invasive cells was approximately 3-fold higher than in PC-3 Low Invasive cells while the COX-1 expression was similar in both cell sublines. When incubated with arachidonic acid, PGE2 was the major prostaglandin produced by these cells. PC-3 High Invasive cells produced PGE2 approximately 2.5-fold higher than PC-3 Low Invasive cells. PGD2 was the second most abundant prostaglandin produced by these cells. Both indomethacin (a nonspecific COX inhibitor) and NS-398 (a specific COX-2 inhibitor) inhibited the production of prostaglandins and the cell invasion. PGE2 alone did not induce the cell invasion of PC-3 Low Invasive cells. However, PGE2 reversed the inhibition of cell invasion by NS-398 and enhanced the cell invasion of the PC-3 High Invasive cells. In contrast, PGD2 slightly inhibited the cell invasion. These results suggest that in the PC-3 Low Invasive cells, COX-2-derived PGE2 may not be sufficient to induce cell invasion while in the PC-3 High Invasive cells, PGE2 may be sufficient to act as an enhancer for the cell invasion. Further, PGD2 may represent a weak inhibitor and counteracts the effect of PGE2 in the cell invasion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498388     DOI: 10.1023/a:1020915914376

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  70 in total

1.  PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2.

Authors:  L R Howe; H C Crawford; K Subbaramaiah; J A Hassell; A J Dannenberg; A M Brown
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

Review 2.  Inhibition of cyclooxygenase: a novel approach to cancer prevention.

Authors:  K Subbaramaiah; D Zakim; B B Weksler; A J Dannenberg
Journal:  Proc Soc Exp Biol Med       Date:  1997-11

3.  A new in vitro assay for quantitating tumor cell invasion.

Authors:  L A Repesh
Journal:  Invasion Metastasis       Date:  1989

4.  Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression.

Authors:  Y Higashi; T Kanekura; T Kanzaki
Journal:  Int J Cancer       Date:  2000-06-01       Impact factor: 7.396

Review 5.  Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.

Authors:  G N Levy
Journal:  FASEB J       Date:  1997-03       Impact factor: 5.191

6.  Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment.

Authors:  S Madaan; P D Abel; K S Chaudhary; R Hewitt; M A Stott; G W Stamp; E N Lalani
Journal:  BJU Int       Date:  2000-10       Impact factor: 5.588

7.  Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.

Authors:  V Subbarayan; A L Sabichi; N Llansa; S M Lippman; D G Menter
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

8.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

9.  Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: effects of fatty acids and cyclooxygenase inhibitors.

Authors:  A A Chaudry; K W Wahle; S McClinton; L E Moffat
Journal:  Int J Cancer       Date:  1994-04-15       Impact factor: 7.396

10.  Evidence for separate mechanisms of antiproliferative action of indomethacin and prostaglandin on MCF-7 breast cancer cells.

Authors:  P Planchon; N Veber; V Magnien; G Prévost; A B Starzec; L Israël
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

View more
  24 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.

Authors:  Tian-Bao Huang; Yang Yan; Zhui-Feng Guo; Xiao-Long Zhang; Huan Liu; Jiang Geng; Xu-Dong Yao; Jun-Hua Zheng
Journal:  Int Urol Nephrol       Date:  2014-04-01       Impact factor: 2.370

3.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

4.  Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output.

Authors:  M E Miller; A C Holloway; W G Foster
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies.

Authors:  Wei Zhu; Bing-bing Wei; Xia Shan; Ping Liu
Journal:  Mol Biol Rep       Date:  2009-08-09       Impact factor: 2.316

6.  Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysis.

Authors:  Jia-Li Liu; Yuan Liang; Zhen-Ning Wang; Xin Zhou; Li-Li Xing
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

7.  Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.

Authors:  Andrea Schmidt; James Sinnett-Smith; Steven Young; Hui-Hua Chang; O Joe Hines; David W Dawson; Enrique Rozengurt; Guido Eibl
Journal:  Surgery       Date:  2017-02-20       Impact factor: 3.982

8.  A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells.

Authors:  Kasem Nithipatikom; Michael P Endsley; Marilyn A Isbell; Craig E Wheelock; Bruce D Hammock; William B Campbell
Journal:  Biochem Biophys Res Commun       Date:  2005-07-15       Impact factor: 3.575

9.  Expression and function of fatty acid amide hydrolase in prostate cancer.

Authors:  Michael P Endsley; Rebecca Thill; Iffat Choudhry; Carol L Williams; Andre Kajdacsy-Balla; William B Campbell; Kasem Nithipatikom
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

10.  Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells.

Authors:  Jin Ming Di; Jun Pang; Qi Peng Sun; Yan Zhang; You Qiang Fang; Xiao Pen Liu; Jian Hua Zhou; Xing Xing Ruan; Xin Gao
Journal:  Mol Biol Rep       Date:  2009-07-19       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.